FASLG and autoimmune polyendocrinopathy: Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the persistent positivity of at least one antiphospholipid antibody (aPL) along with thrombotic or non-thrombotic manifestations described in the 2023 ACR/EULAR classification criteria [9].